XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Revenues        
Revenue $ 24,219,445 $ 4,426,898 $ 62,863,128 $ 13,280,565
Cost of Revenue 14,614,754 1,098,137 36,904,527 3,081,112
Gross profit 9,604,691 3,328,761 25,958,601 10,199,453
Operating expenses        
Sales and marketing 3,476,918 1,085,823 9,210,303 3,821,081
Distribution costs 2,578,180 605,368 8,641,559 1,538,830
General and administrative expenses 2,878,255 1,970,276 8,287,779 6,556,627
Share-based compensation 1,146,299 854,013 3,126,472 2,333,306
Amortization of acquired intangible assets 1,691,243 236,001 3,534,216 540,836
Depreciation 232,492 115,011 669,540 361,590
Operating Expenses 12,003,387 4,866,492 33,469,869 15,152,270
Loss from operations (2,398,696) (1,537,731) (7,511,268) (4,952,817)
Other income (expenses), net        
Interest (expense) income, net (154,999) (19,705) (2,380,972) (61,699)
Change in derivative liability 0 0 (1,770) 0
Gain on sale of Infusionz and select assets 0 0 7,564,363 0
Gain (loss) on sale of property and equipment 0 5,500 0 5,500
Gain on SBA PPP loan extinguishment 0 0 0 300,995
Other income (expense), net (154,999) (14,205) 5,181,621 244,796
Net loss before income tax (2,553,695) (1,551,936) (2,329,647) (4,708,021)
Income tax benefit 496,880 1,351,686 449,828 1,116,653
Net loss from continuing operations (2,056,815) (200,250) (1,879,819) (3,591,368)
Loss (income) from discontinued operations 288,127 147,583 (50,291) 4,115,245
Net loss attributable to non-controlling interest 124,804 0 358,390 0
Net (loss) income attributable to Upexi, Inc. $ (1,643,884) $ (52,667) $ (1,571,720) $ 523,877
Basic income (loss) per share:        
Loss per share from continuing operations $ (0.11) $ (0.01) $ (0.11) $ (0.22)
Income (loss) per share from discontinued operations 0.02 0.01 (0.00) 0.26
Total (loss) income per shares (0.11) (0.00) (0.11) 0.03
Diluted (loss) income per share:        
Loss per share from continuing operation (0.11) (0.01) (0.11) (0.20)
Income (loss) per share from discontinued operation 0.02 0.01 (0.00) 0.23
Total (loss) income per share $ (0.11) $ (0.00) $ (0.11) $ 0.03
Basic weighted average shares outstanding 18,015,837 16,426,399 17,418,877 16,080,699
Fully diluted weighted average shares outstanding 18,015,837 17,821,810 17,418,877 17,586,030